These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35759529)

  • 1. SARS-CoV-2 Infection in Patients with a History of VITT.
    Schönborn L; Seck SE; Thiele T; Warkentin TE; Greinacher A
    N Engl J Med; 2022 Jul; 387(1):88-90. PubMed ID: 35759529
    [No Abstract]   [Full Text] [Related]  

  • 2. VITT with inactivated SARS-CoV-2 vaccine - index case.
    Devi K; Ali N; Nasir N; Mahmood SF
    Hum Vaccin Immunother; 2022 Dec; 18(1):2036556. PubMed ID: 35254213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).
    Parums DV
    Med Sci Monit; 2021 Apr; 27():e932899. PubMed ID: 33900279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune thrombocytopenia following SARS-CoV-2 vaccination in a female: Report of one case.
    Lee ZM; Chen YC; Liu SC; Wang CC
    Pediatr Blood Cancer; 2023 May; 70(5):e30211. PubMed ID: 36726145
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune Thrombocytopenic Purpura (ITP) Triggered by COVID-19 Infection and Vaccination.
    David P; Dotan A; Mahroum N; Shoenfeld Y
    Isr Med Assoc J; 2021 Jun; 23(6):378-380. PubMed ID: 34155853
    [No Abstract]   [Full Text] [Related]  

  • 6. Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.
    Fang F; Tse B; Pavenski K
    BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35902184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
    Candelli M; Rossi E; Valletta F; De Stefano V; Franceschi F
    Br J Haematol; 2021 Aug; 194(3):547-549. PubMed ID: 33934330
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual.
    Ogai A; Yoshida R; Yuasa C; Chin K; Fujimaki K; Nakajima H
    Int J Hematol; 2022 Feb; 115(2):293-295. PubMed ID: 34716890
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
    Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
    Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
    [No Abstract]   [Full Text] [Related]  

  • 12. The known knowns and known unknowns of vaccine-induced thrombotic thrombocytopaenia.
    McFadyen JD; Peter K
    Cardiovasc Res; 2021 Sep; 117(11):e147-e150. PubMed ID: 34472568
    [No Abstract]   [Full Text] [Related]  

  • 13. Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination.
    Saito K; Ichikawa S; Hatta S; Katsuoka Y; Harigae H; Izumi T
    Ann Hematol; 2022 Apr; 101(4):885-887. PubMed ID: 34599382
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine.
    Banerjee S; Sandhu M; Tonzi E; Tambe A; Gambhir HS
    Am J Ther; 2021 Aug; 28(5):e604-e606. PubMed ID: 34469919
    [No Abstract]   [Full Text] [Related]  

  • 15. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
    Favaloro EJ
    Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.
    Hung YT; Huang YL; Chang YY; Chen WT
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e429-e431. PubMed ID: 35176191
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
    Pavord S; Hunt BJ; Horner D; Bewley S; Karpusheff J;
    BMJ; 2021 Oct; 375():n2195. PubMed ID: 34598931
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura.
    Shah H; Kim A; Sukumar S; Mazepa M; Kohli R; Braunstein EM; Brodsky RA; Cataland S; Chaturvedi S
    Blood; 2022 Apr; 139(16):2570-2573. PubMed ID: 35259252
    [No Abstract]   [Full Text] [Related]  

  • 19. De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.
    Moulis G; Crickx E; Thomas L; Massy N; Mahévas M; Valnet-Rabier MB; Atzenhoffer M; Michel M; Godeau B; Bagheri H; Salvo F;
    Blood; 2022 Apr; 139(16):2561-2565. PubMed ID: 35446373
    [No Abstract]   [Full Text] [Related]  

  • 20. Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
    Scanvion Q; Lambert M; Hachulla E; Terriou L
    Br J Haematol; 2021 Sep; 194(6):e93-e95. PubMed ID: 34114220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.